Table 1.
Primers used for PCR amplifications, identified by laboratory number
Primer | Position | Sequence |
---|---|---|
1407 | P1 B/B | CTCAGGAATTCCACCATGAATGAAACAGAGTGC |
4017 | P2 B/B | CGCGGATCCATCGATGGGTGCG |
4968 | P1 B/S | ATCAGGATCCGCGGAGATTCGGATTGCG |
4969 | P2 B/S | ATCAGTCGACGCAGTCCTGGCAGAACGGC |
4970 | P1S/X | ATCAGTCGACCCGCTGCTCTTTTCGGTGC |
4971 | P2 S/X | ATCATCTAGAGTTAACTATGCATAATCTGGGACG |
4018 | MP2 48 | GTCTTCTGTGCGAATAAGTTG |
4019 | MP1 48 | CAACTTATTGGCACAGGAGAC |
4020 | MP2 133 | CCAAGCATAATGGCCACGAAG |
4021 | MP1 133 | CTTCGTGGCCATTATGCTTGG |
4972 | MP2 133/134 | AGCATAATGGCCGCGAAGAAGGCCAAGTCCTTAATCG |
4973 | MP1 133/134 | GCCTTCTTCGCGGCCATTATGCTTGGGTAGGTGAC |
4974 | MP2 325 | GTGAGAGCGACGAGAGCCATCAACCAGGG |
4975 | MP1 325 | GCTCTCGTCGCTCTCACGGCAGCCCGGTAG |
4976 | MP2 335 | GCTTCAAGGCCACCAAGGGTTCCAAGGGCATCG |
4977 | MP1 335 | CCCTTGGTGGCCTTGAAGCCCTGGTTGATGGC |
4978 | MP2 352 | AACGCCTCGCATTGCGCATACATAGAGGACGAG |
4979 | MP1 352 | ATGCGCAATGCGAGGCGTTGCTCCTCGAAGC |
4980 | MP2 393 | AGTACGCCGCTAGGCGACTGCACCACCACG |
4981 | MP1393 | AGTCGCCTAGCGGCGTACTTCGACAACCTCTC |
4982 | MP2 598 | AGTCCGTCGCCTTGAAGAGCTCCCGCCGGGG |
4983 | MP1598 | CTCTTCAAGGCGACGGACTGGCGGGAGCAG |
4984 | MP2 601/602 | CCTTGAAGGCGGCCCGCCGGGGATCTGACATGTC |
4985 | MP1 601/602 | CCCCGGCGGGCCGCCTTCAAGGAGACGGACTGGC |
P denotes flanking primer, where P1 represents the primer binding to the very 5′ end, and P2 represents binding to the very 3′ end of the restriction fragment; MP denotes mutagenesis primer, with MP1 primers allowing amplification in 5′–3′ direction, and MP2 primers allowing amplification in 3′–5′ direction. Amplifications were performed on restriction fragments of DmOctα1Rb: BamHI (B)/B, B/SalI (S), and S/XbaI (X). Positions of mutated amino acids are indicated with the respective MPs. Nucleotide sequence of primers is in 5′–3′ direction. Triplets encoding the modified residues are underscored.